CCN2 and neoplasm: In FBC, any CTGF expression (in stromal and/or tumor cells) was seen in 71/75 (94.7%) of cases, stromal cell expression in 69/75 (82%) of cases of which 35 (50.7%) showed high expression, and CTGF expression in tumor cells in 18/75 (24%) of cases.